Fulminant Liver Failure Induced by Hepatosplenic αβ T-Cell Lymphoma

Zeitschrift fur Gastroenterologie

Volumn 41, Issue 11, 2003, Pages 1083-1086

  Petersen Benz, C ^a   Hoffmann, N ^a   Beckurts, T ^a   Goeser, T ^a   Steffen, H M ^a   Dries, V ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

T cell lymphoma; Acute liver failure; Hepatosplenic lymphoma; Liver transplantation; Necrotizing hepatitis

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CORTICOSTEROID THERAPY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT CONTRAINDICATION;

ADULT; BIOPSY; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER; LIVER FAILURE; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; SPLEEN; SPLENIC NEOPLASMS;

EID: 0344552761     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44298     Document Type: Article

References (14)

1. Blakolmer K, Gaulard P, Mannhalter C et al. Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. Transplantation 2000; 70 (12):1802-1805
2. Thompson DR, Faust TW, Stone MJ et al. Hepatic failure as the presenting manifestation of malignant lymphoma. Clin Lymphoma 2001; 2 (2): 123-128
3. Scoazec JY, Degott C, Brousse N et al. Non-Hodgkin's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients. Hepatology 1991; 13 (5): 870-875
4. Cooke CB, Krenacs L, Stetler-Stevenson M et al. Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic αβ T-cell origin. Blood 1996; 88 (11): 4265-4274
5. Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program) 2001: 259-281 (Review)
6. Macon WR, Levy NB, Kurtin PJ et al. Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 2001; 25 (3): 285-296
7. Suarez F, Wlodarska I, Rigal-Huguet F et al. Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma. Am J Surg Pathol 2000; 24 (7): 1027-1032
8. Anthony PP, Sarsfield P, Clarke T. Primary lymphoma of the liver: clinical and pathological features of 10 patients. J Clin Pathol 1990; 43 (12): 1007-1013
9. Gaulard P, Zafrani ES, Mavier P et al. Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases. Hepatology 1986; 6: 864-868
10. Harris A, Ben-Ezra J, Contos MJ et al. Malignant lymphoma can present as hepatobiliary disease. Cancer 1996; 78: 2011-2019
11. Salhany KE, Feldman M, Kahn MJ et al. Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation. Hum Pathol 1997; 28 (6): 674-685
12. Wong KF, Chan JK, Matutes E et al. Hepatosplenic gamma delta T-cell lymphoma. A distinctive aggressive lymphoma type. Am J Surg Pathol 1995; 19 (6): 718-726
13. Francois A, Lesesve JF, Stamatoullas A et al. Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. Am J Surg Pathol 1997; 21 (7): 781-790
14. Aldinucci D, Poletto D, Zagonel V et al. In vitro and in vivo effects of 2′-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies. Br J Haematol 2000; 110 (1): 188-196